Yesterday
Episode 145: Myeloma Series, Pt. 6 - First line treatment of Multiple Myeloma (2026)
This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ... Show More
40m 27s
Jan 7
Episode 144: Myeloma Series, Pt. 5 - Myeloma Risk Stratification and Response Criteria (2026)
This week, we introduce a new episode for our myeloma series, this time focusing on risk stratification and response criteria. The initial workup and surveillance labs are expansive, but all of the studies we do have a purpose. Many present-day studies also use “minimal residual ... Show More
29m 16s
Dec 30
Episode 143: Myeloma Series, Pt. 4 - Myeloma Pharmacology (2025)
We bring back our prior pharmacology discussion because it’s so incredibly important for the conversations that are on the horizon over the next few weeks. In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing f ... Show More
48m 42s
Sep 2025
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Nov 7
S7 E3: Anti-Ds side effects; knee OA exercise; PSA trends & PCUK interview with Dr Bunmi Olajide & Kevin Howell
Welcome back to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we look at three new pieces of research and have a special interview in conjunction with Prostate Cancer UK. First, do antidepressants have physiological side effects? How do they compare ... Show More
37m 26s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
<p>Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and t ... Show More
24m 31s
Oct 16
53: Can Thyroid Health Help Prevent Cancer? – The Root-Cause Approach to Healing with Dr. Leigh Erin Connealy
Can thyroid issues increase your cancer risk—or could they hold the key to preventing it altogether?In this episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson welcomes renowned integrative physician Dr. Leigh Erin Connealy, author of The Cancer Revolution. ... Show More
53m 29s
Colorectal cancer is one of the most common cancers diagnosed each year worldwide. This highly anticipated series will take an in-depth look at this disease. In this first episode, we discuss the basics, including staging, tumor markers, and microsatellite instability testing, before tackling the management of colorectal cancer in upcoming episodes.
Conten ... Show More
<p data-start="216" data-end="681"><span data-fontfamily= "Montserrat">In this week's episode of <em data-start="261" data-end="281">The Dr. Ardis Show</em>, Dr. Ardis sounds the alarm on one of the most widely prescribed thyroid medications in America - levothyroxine. Used by ov ... Show More
